Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-24

Clinical Trial Update: Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update investigating prediction of analgesic response to ibuprofen after third-molar extraction; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: University of Pennsylvania | Conditions: Impacted Third Molar Tooth, Pain, Acute | Phase 1 | Status: COMPLETED